Drug:
Reaction: PRURITUS
20250101 - 20251231
No. 701 - 800
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
701 | 25105983 |
US |
2 | |
Skin exfoliation, Chemical burn, Erythema, Pruritus, |
||||
NORELGESTROMIN AND ETHINYL ESTRADIOL, METHYLPHENIDATE HYDROCHLORIDE, DIAZEPAM, RISPERIDONE, HYDROXYZINE, FOLIC ACID, |
||||
702 | 25105988 |
GB |
2 | |
Lower respiratory tract infection, Malaise, Complication associated with device, Chest pain, Limb discomfort, Psoriasis, Pruritus, Hypertension, |
||||
SECUKINUMAB, |
||||
703 | 25106093 |
CA |
2 | |
Abdominal pain, Abdominal pain upper, Burning sensation, Fatigue, Hypertension, Kidney infection, Pruritus, Renal failure, |
||||
METHOTREXATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, FOLIC ACID, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, |
||||
704 | 25106226 |
US |
79 | 1 |
Pruritus, Neuropathy peripheral, Fatigue, Diarrhoea, |
||||
LISINOPRIL, LISINOPRIL, AMLODIPINE, |
||||
705 | 25106264 |
US |
62 | 1 |
Heart rate increased, Rhinitis, Dry skin, Pruritus, Dysphonia, Fatigue, Platelet count decreased, |
||||
LENVATINIB, LENVATINIB, INSULIN GLARGINE, DULAGLUTIDE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, GABAPENTIN, PREDNISONE, METHOCARBAMOL, METHOCARBAMOL TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
706 | 25106283 |
JP |
2 | |
Melaena, Syncope, Frequent bowel movements, Anal haemorrhage, Feeling abnormal, Tinnitus, Insomnia, Eczema, Pruritus, Angioedema, Diarrhoea, Nausea, Abdominal pain, Headache, Pain in extremity, |
||||
TADALAFIL, SELEXIPAG, WARFARIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MACITENTAN, |
||||
707 | 25106513 |
CO |
39 | 2 |
Pyelocaliectasis, Dysgeusia, Application site discolouration, Papule, Skin exfoliation, Pain of skin, Pain, Somnolence, Treatment noncompliance, Therapy interrupted, Accidental exposure to product, Wrong technique in product usage process, Arthropathy, Osteoarthritis, Erythema, Pruritus, |
||||
MECHLORETHAMINE HYDROCHLORIDE, MECHLORETHAMINE HYDROCHLORIDE, MECHLORETHAMINE HYDROCHLORIDE, ESZOPICLONE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, ESCITALOPRAM OXALATE, ESCITALOPRAM, QUETIAPINE FUMARATE, QUETIAPINE, SERTRALINE HYDROCHLORIDE, |
||||
708 | 25106748 |
FR |
34 | 2 |
Myositis, Muscular weakness, Neuromyelitis optica spectrum disorder, Pruritus, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, PACLITAXEL, HYDROXYCHLOROQUINE SULFATE, |
||||
709 | 25106763 |
US |
95 | 1 |
Musculoskeletal disorder, Pruritus, Injection site reaction, Rash, |
||||
RISANKIZUMAB-RZAA, HYDROCORTISONE, |
||||
710 | 25106772 |
EG |
32 | 1 |
Swelling face, Dyspnoea, Hypotension, Rash, Pruritus, Urticaria, Hypersensitivity, Drug hypersensitivity, Angioedema, |
||||
CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
711 | 25106814 |
SE |
78 | 2 |
Rash, Pruritus, Overdose, Device malfunction, |
||||
ROTIGOTINE, ROTIGOTINE, |
||||
712 | 25107029 |
US |
63 | 1 |
Rash pruritic, Pruritus, |
||||
713 | 25107111 |
ES |
56 | 2 |
Dyspnoea, Abdominal pain, Pruritus, Infusion related hypersensitivity reaction, |
||||
PACLITAXEL, |
||||
714 | 25107143 |
US |
1 | |
Pruritus, |
||||
SUZETRIGINE, |
||||
715 | 25107223 |
US |
||
Pruritus, Product availability issue, |
||||
RUXOLITINIB, |
||||
716 | 25107232 |
US |
1 | |
Pruritus, |
||||
LECANEMAB, |
||||
717 | 25107279 |
US |
||
Weight decreased, Pruritus, |
||||
PANCRELIPASE, |
||||
718 | 25107412 |
US |
||
Peripheral swelling, Pruritus, |
||||
ATOGEPANT, |
||||
719 | 25112032 |
57 | 2 | |
Injection site rash, Pruritus, |
||||
ETANERCEPT, |
||||
720 | 25112179 |
51 | 2 | |
Pruritus, Rash, Rash, |
||||
721 | 25112871 |
65 | 2 | |
Fatigue, Headache, Nausea, Pruritus, Asthenia, Dizziness, Oropharyngeal pain, Stomatitis, Tongue eruption, Infusion related reaction, Product quality issue, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
722 | 25097367 |
US |
78 | 2 |
Pruritus, Skin haemorrhage, Skin weeping, Dry skin, Skin fissures, |
||||
DUPILUMAB, DUPILUMAB, |
||||
723 | 25097368 |
US |
54 | 2 |
Idiopathic urticaria, Condition aggravated, Rash, Pruritus, Burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
724 | 25097369 |
US |
37 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
725 | 25097543 |
US |
18 | 1 |
Pruritus, Erythema, |
||||
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
726 | 25097582 |
US |
8 | 2 |
Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
727 | 25097624 |
US |
40 | 2 |
Urticaria, Pruritus, |
||||
FERRIC DERISOMALTOSE, FERRIC DERISOMALTOSE, |
||||
728 | 25097625 |
US |
2 | |
Rash, Pruritus, Condition aggravated, |
||||
GABAPENTIN, |
||||
729 | 25097696 |
US |
||
Pruritus, |
||||
ISTRADEFYLLINE, ISTRADEFYLLINE, ISTRADEFYLLINE, AMANTADINE, |
||||
730 | 25097749 |
HU |
||
Dyspnoea, Erythema, Pruritus, |
||||
OCRELIZUMAB, |
||||
731 | 25097804 |
US |
79 | 1 |
Pruritus, Condition aggravated, Injection site rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
732 | 25097830 |
US |
66 | 1 |
Abdominal pain upper, Arthralgia, Myalgia, Brain fog, Fatigue, Constipation, Weight decreased, Vision blurred, Vitreous floaters, Depression, Pruritus, Drug intolerance, |
||||
LENALIDOMIDE, |
||||
733 | 25097909 |
US |
24 | 2 |
Pruritus, Dry skin, Skin exfoliation, Skin haemorrhage, Skin weeping, Skin fissures, Eczema, |
||||
DUPILUMAB, |
||||
734 | 25097919 |
CA |
2 | |
Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, CALCIUM GLUCONATE, DESOGESTREL AND ETHINYL ESTRADIOL, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
735 | 25098050 |
SG |
61 | 2 |
Pruritus, |
||||
LEFLUNOMIDE, |
||||
736 | 25098167 |
US |
33 | 1 |
Pruritus, Swelling, Dermatitis atopic, Sensitive skin, |
||||
TRALOKINUMAB-LDRM, |
||||
737 | 25098169 |
US |
78 | 2 |
Eczema, Pain of skin, Pruritus, Erythema, Rash vesicular, |
||||
DUPILUMAB, DUPILUMAB, |
||||
738 | 25098211 |
US |
50 | 2 |
Swelling face, Skin warm, Pruritus, |
||||
LEVOTHYROXINE SODIUM, GALCANEZUMAB-GNLM, |
||||
739 | 25098244 |
US |
40 | 2 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
740 | 25098245 |
US |
35 | 1 |
Skin exfoliation, Pruritus, |
||||
DUPILUMAB, |
||||
741 | 25098280 |
CN |
53 | 2 |
Swelling face, Pruritus, Immune system disorder, |
||||
IODIXANOL, |
||||
742 | 25098324 |
IT |
||
Drug hypersensitivity, Pruritus, Papule, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
743 | 25098347 |
US |
54 | 2 |
Dry skin, Skin exfoliation, Dermatitis atopic, Pruritus, Dry eye, Eye pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
744 | 25098393 |
US |
79 | 1 |
Pruritus, |
||||
745 | 25098407 |
US |
66 | 1 |
Pruritus, Taste disorder, Dysgeusia, |
||||
MARIBAVIR, |
||||
746 | 25098416 |
US |
2 | |
Pruritus, Rash, Urticaria, Drug hypersensitivity, |
||||
OMALIZUMAB, |
||||
747 | 25098512 |
US |
2 | |
Pruritus, |
||||
ODEVIXIBAT, NALTREXONE HYDROCHLORIDE, URSODIOL, URSOSIOL, ERGOCALCIFEROL, RIFAMPIN, VITAMIN E, CREAM, |
||||
748 | 25098514 |
US |
51 | 2 |
Pruritus, |
||||
AVAPRITINIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CELECOXIB, SPIRONOLACTONE, OXYCODONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SERTRALINE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, CETIRIZINE HYDROCHLORIDE, LORAZEPAM, CARISOPRODOL, |
||||
749 | 25098637 |
US |
||
Nasal congestion, Headache, Pruritus, Inflammation, Drug hypersensitivity, |
||||
MESALAMINE, |
||||
750 | 25098842 |
US |
8 | 2 |
Pruritus, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
751 | 25098889 |
SA |
73 | 1 |
Pruritus, Inappropriate schedule of product administration, |
||||
INCLISIRAN, |
||||
752 | 25098902 |
US |
2 | |
Pruritus, White blood cell count decreased, Off label use, |
||||
LENALIDOMIDE, |
||||
753 | 25098937 |
CA |
2 | |
Pulmonary fibrosis, Wheezing, Stomatitis, Psoriatic arthropathy, Weight increased, Synovitis, Peripheral swelling, Rheumatoid arthritis, Pericarditis, Systemic lupus erythematosus, Weight decreased, Rash vesicular, Swelling, Wound, Pneumonia, Psoriasis, Sleep disorder due to general medical condition, insomnia type, Urticaria, Pyrexia, Wound infection, Rash, X-ray abnormal, Rheumatic fever, Sinusitis, Vomiting, Subcutaneous drug absorption impaired, Type 2 diabetes mellitus, Sleep disorder, Pemphigus, Pruritus, Rheumatoid factor positive, Swollen joint count increased, Pustular psoriasis, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SULFASALAZINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, OXYCODONE, LISINOPRIL, DESOGESTREL AND ETHINYL ESTRADIOL, CALCIUM GLUCONATE, LANSOPRAZOLE, LORAZEPAM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, QUETIAPINE FUMARATE, QUETIAPINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ADALIMUMAB-ADAZ, RAMIPRIL, |
||||
754 | 25098950 |
US |
66 | 1 |
Diarrhoea, Eczema, Erythema, Pruritus, Skin fissures, |
||||
DUPILUMAB, DUPILUMAB, |
||||
755 | 25098965 |
US |
72 | 1 |
Pruritus, Off label use, |
||||
THALIDOMIDE, |
||||
756 | 25099032 |
US |
67 | 1 |
Rash, Pruritus, |
||||
LENALIDOMIDE, |
||||
757 | 25099040 |
US |
1 | |
Pneumonia, Muscular weakness, Cyst, Onychomadesis, Dry skin, Decreased appetite, Dry mouth, Dysphagia, Rash, Pruritus, Onychalgia, Pain in extremity, T-lymphocyte count decreased, Pain in extremity, |
||||
TALQUETAMAB, |
||||
758 | 25099065 |
US |
2 | |
Weight increased, Catheter site haemorrhage, Drug hypersensitivity, Laryngospasm, Dyspnoea, Pruritus, |
||||
MORPHINE, GABAPENTIN, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
759 | 25099102 |
US |
74 | 1 |
Sleep disorder, Pruritus, Rash, Neurodermatitis, |
||||
DUPILUMAB, |
||||
760 | 25099106 |
US |
68 | 2 |
Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
761 | 25099110 |
US |
67 | 1 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, IVERMECTIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, VORTIOXETINE, BUPROPION HYDROCHLORIDE, BUPROPION, PIMECROLIMUS, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, FINASTERIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, TADALAFIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FAMOTIDINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LORAZEPAM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, |
||||
762 | 25099149 |
US |
||
Liver injury, Pruritus, |
||||
MARALIXIBAT CHLORIDE, |
||||
763 | 25099206 |
US |
84 | 2 |
Haemorrhage, Contusion, Pruritus, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
764 | 25099253 |
US |
29 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
765 | 25099282 |
US |
25 | 2 |
Dermatitis atopic, Dermatitis, Pruritus, |
||||
DUPILUMAB, |
||||
766 | 25099294 |
US |
24 | 1 |
Headache, Dizziness, Pruritus, |
||||
OMALIZUMAB, |
||||
767 | 25099304 |
US |
69 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
768 | 25099307 |
US |
37 | 1 |
Injection site mass, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
769 | 25099562 |
US |
42 | 2 |
Dry skin, Pruritus, Drug dose omission by device, Device operational issue, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
770 | 25099615 |
US |
1 | |
Rebound eczema, Erythema, Rash, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, RUXOLITINIB, |
||||
771 | 25099716 |
BR |
||
Colitis ulcerative, Malaise, Arthritis, Osteitis, Pain in extremity, Pruritus, Influenza, Arthralgia, Hypoaesthesia, Therapeutic response shortened, Intentional dose omission, Drug ineffective, Therapy interrupted, Intentional product use issue, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, LOSARTAN, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, CLONAZEPAM, TRAZODONE HYDROCHLORIDE, LITHIUM, LITHIUM BROMATUM, TRAZODONE HYDROCHLORIDE, |
||||
772 | 25099722 |
US |
67 | 1 |
Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
773 | 25099723 |
US |
80 | 1 |
Eczema, Middle insomnia, Dry skin, Skin fissures, Pruritus, Skin exfoliation, Scratch, |
||||
DUPILUMAB, APIXABAN, |
||||
774 | 25099803 |
PT |
22 | 2 |
Hypersensitivity, Product use in unapproved indication, Off label use, Rash, Pruritus, Hypotension, Discomfort, |
||||
DOXORUBICIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, VINORELBINE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINBLASTINE SULFATE, VINBLASTINE SULFATE, VINBLASTINE SULFATE, BLEOMYCIN SULFATE, BLEOMYCIN SULFATE, BLEOMYCIN SULFATE, DACARBAZINE, DACARBAZINE, DACARBAZINE, BLEOMYCIN, BLEOMYCIN SULFATE, BLEOMYCIN, BLEOMYCIN SULFATE, DACARBAZINE, DACARBAZINE, |
||||
775 | 25099860 |
US |
37 | 2 |
Dermatitis atopic, Rash erythematous, Pruritus, |
||||
DUPILUMAB, |
||||
776 | 25100268 |
US |
1 | |
Anaphylactic reaction, Urticaria, Pruritus, Dyspnoea, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
777 | 25100388 |
US |
74 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
778 | 25100402 |
US |
65 | 2 |
Sinusitis, Ear infection, Upper respiratory tract infection, Paraesthesia oral, Lip swelling, Rash, Pruritus, |
||||
TOFACITINIB, DIPHENHYDRAMINE HCL, |
||||
779 | 25100477 |
US |
44 | 2 |
Pruritus, Erythema, |
||||
GADOBUTROL, |
||||
780 | 25100494 |
CA |
44 | 2 |
Peripheral swelling, Peripheral venous disease, Pruritus, Pyrexia, Rash, Rheumatic fever, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder due to general medical condition, insomnia type, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, FLUOROMETHOLONE, RITUXIMAB, RITUXIMAB, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, MAGNESIUM, PREGABALIN, PREGABALIN, SECUKINUMAB, SECUKINUMAB, MORPHINE, ALBUTEROL SULFATE, ALBUTEROL, LORAZEPAM, ERGOCALCIFEROL, LANSOPRAZOLE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALBUTEROL SULFATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CALCIUM, VITAMIN C, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RAMIPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LORAZEPAM, CAFFEINE, CAFFEINE CITRATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, CALCIUM CARBONATE, ANTACID, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERYTHROMYCIN, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYALURONIDASE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LISINOPRIL, MELOXICAM, MESALAMINE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, APREMILAST, APREMILAST, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, LISINOPRIL, TOFACITINIB, LANSOPRAZOLE, |
||||
781 | 25100545 |
US |
75 | 1 |
Dermatitis atopic, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
782 | 25100618 |
US |
70 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
783 | 25100624 |
US |
2 | |
Influenza, Stress, Pruritus, Inappropriate schedule of product administration, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, ERGOCALCIFEROL, VITAMIN E, CREAM, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, GABAPENTIN, ESTRADIOL AND PROGESTERONE, DEXTROAMPHETAMINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, LINACLOTIDE, |
||||
784 | 25100705 |
PT |
1 | |
Depressed level of consciousness, Infection, Swelling face, Condition aggravated, Rash erythematous, Pruritus, Malaise, |
||||
ENZALUTAMIDE, |
||||
785 | 25100777 |
US |
72 | 1 |
Eye infection, Eczema, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
786 | 25100822 |
US |
||
Pruritus, Inappropriate schedule of product administration, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
787 | 25100889 |
US |
70 | 2 |
Pruritus, Incorrect dose administered, Product dose omission issue, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
788 | 25100918 |
PT |
69 | 1 |
Musculoskeletal pain, Pruritus, Pain, Papule, |
||||
CABOTEGRAVIR SODIUM, |
||||
789 | 25100941 |
US |
2 | |
Pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
790 | 25100955 |
US |
||
Acne pustular, Pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
791 | 25100960 |
US |
||
Pruritus, Circumstance or information capable of leading to medication error, |
||||
NEMOLIZUMAB-ILTO, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
792 | 25100979 |
US |
57 | 1 |
Eczema, Erythema, Pruritus, Intentional product misuse, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
793 | 25101010 |
US |
||
Pruritus, Inappropriate schedule of product administration, |
||||
NEMOLIZUMAB-ILTO, |
||||
794 | 25101016 |
US |
||
Pruritus, Sleep disorder, |
||||
NEMOLIZUMAB-ILTO, |
||||
795 | 25101027 |
CA |
61 | 1 |
Psoriatic arthropathy, Oral surgery, Rheumatoid arthritis, Chest discomfort, Adverse drug reaction, Inflammation, Cough, Dyspnoea, Asthma, Pain, Headache, Injection site pain, Psoriasis, Urticaria, Pruritus, Nasopharyngitis, Rhinorrhoea, Oropharyngeal pain, COVID-19, |
||||
ADALIMUMAB, PREDNISONE, |
||||
796 | 25101041 |
US |
||
Pruritus, Dry skin, |
||||
NEMOLIZUMAB-ILTO, VENLAFAXINE HYDROCHLORIDE, ERGOCALCIFEROL, PROGESTERONE, SUMATRIPTAN, ESZOPICLONE, MODAFINIL, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
797 | 25101042 |
US |
||
Injection site swelling, Pruritus, Pain, Incorrect dose administered, Intentional product use issue, Off label use, Intentional overdose, |
||||
NEMOLIZUMAB-ILTO, TADALAFIL, FAMOTIDINE, |
||||
798 | 25101048 |
US |
||
Eczema, Urticaria, Pruritus, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
799 | 25101063 |
US |
2 | |
Pruritus, |
||||
COLLAGENASE SANTYL, |
||||
800 | 25101119 |
US |
||
Pruritus, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28